[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"brand-huiyuzhiyao":3},{"head":4,"company":38,"invest":43,"children":44,"shops":45,"category":46,"sameIndustry":5,"rid":6},{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"brandId":6,"brandLogo":7,"brandImage":5,"brandName":8,"webName":9,"balias":5,"enterId":10,"mainindustry":11,"industry":5,"brandType":5,"brandHonor":5,"brandTel":12,"establishdate":13,"brandBirth":14,"cityarea":5,"brandWebsite":5,"brandSobp":5,"brandVisit":5,"totalVisits":15,"status":16,"isDeleted":16,"comment":5,"remark":5,"logoExistStatus":17,"imageExistStatus":17,"industryId":5,"industryRanking":5,"score":5,"enterName":18,"mallShopList":19,"brandSummary":5,"likes":5,"unlikes":5,"follow":5,"pagetitle":20,"pagekeywords":21,"pagedesc":22,"brandContent":23,"province":5,"city":5,"area":5,"detailaddress":24,"unifiedscc":25,"enterType":26,"enterLegalperson":27,"enterStablishdate":28,"regauthority":29,"licenseValidity":30,"approvaldate":31,"regcapital":32,"incapital":33,"businessscope":34,"ownBrand":5,"enterTelphone":12,"enterWebsite":35,"business":36,"enterQq":5,"enterMail":37,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"regtrademark":5},null,"50629","\u002Fprofile\u002Fupload\u002F2025\u002F01\u002F25\u002F92e563907508c31ea2ba725bac9f3f1e.gif","汇宇制药","huiyuzhiyao",43792,5593,"0832-8808001","2010年","内江市",322,0,"1","四川汇宇制药股份有限公司",[],"汇宇制药简介-汇宇药物-品牌之家","汇宇制药品牌介绍,汇宇药物好不好,汇宇怎么样,汇宇,四川汇宇制药股份有限公司","汇宇制药品牌简介，品牌之家为你介绍四川汇宇制药股份有限公司旗下汇宇制药品牌信息，包括品牌介绍、联系方式、主营产品、最新评论、点赞数量等，告诉你汇宇药物怎么样，致力于帮助你了解汇宇制药真实有效的品牌相关信息。","汇宇制药成立于2010年，是一家研发驱动的综合制药企业，主要从事抗肿瘤和注射剂药物的研发、生产和销售。公司总部和生产基地位于内江市国家经济技术开发区，研发中心坐落于成都市天府国际生物城，并且在美国、英国和爱尔兰等地设有子公司。\n\n公司的研发团队以经验丰富的海归博士为核心，研发人员近750人，占公司总人数的40%以上，在化学原料药、化学普通注射剂和复杂注射剂等方面有丰富的研发经验。公司积极推进抗肿瘤领域的小分子创新药和生物大分子创新药的研发，在研项目109个，包含12个一类创新药及2个改良新药项目，管线以肿瘤及相关领域为主，同时逐步覆盖其它领域。\n\n在海外，汇宇制药2014年通过英国GMP认证，2015年7月全资子公司英国海玥药业通过欧盟药品放行资质认证，同年自主品牌抗肿瘤注射剂在欧盟实现规模化销售。公司自有或授权合作方持有海外批件超过300件，在近100个国家签订了合作协议，覆盖6大洲。\n\n目前汇宇在英国有16个一线抗肿瘤注射剂及2个其他领域制剂获得上市批准，并在海外超过1000家医疗机构上市销售。公司在2022年下半年接受并顺利完成美国FDA的现场认证，使得公司生产质量管理体系已满足中国、欧盟和美国等主流国际化标准的要求。\n\n在国内，2017年注射用培美曲塞二钠，在同品种中通过一致性评价，次年中标国家集采，在国内开始大规模销售，覆盖了超过2000家等级医院。2021年10月26号正式登陆科创板，成为一家国际化视野的创新药企。目前公司有注射用培美曲塞二钠、多西他赛注射液、注射用阿扎胞苷、紫杉醇注射液、奥沙利铂注射液、注射用盐酸苯达莫司汀、伊立替康注射液、注射用硼替佐米、盐酸帕洛诺司琼注射液、普乐沙福注射液、注射用盐酸表柔比星等 17个药品获批上市，均视同通过注射剂一致性评价。","四川省内江市市中区汉阳路333号3幢","91511000563254776P","股份有限公司(上市、自然人投资或控股)","丁兆","2010-10-12","内江市市场监督管理局","-","2021-11-25","42,360万(元)","36,000万(元)","许可项目：药品生产；药品进出口（依法须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准）一般项目：技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；食品销售（仅销售预包装食品）（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）。","www.huiyupharma.com","医药制造业","huiyu@huiyupharma.com",{"enterId":39,"enterName":18,"province":5,"city":5,"area":5,"detailaddress":24,"unifiedscc":25,"enterType":26,"enterLegalperson":27,"enterStablishdate":28,"regauthority":29,"licenseValidity":30,"approvaldate":31,"regcapital":32,"incapital":33,"businessscope":34,"ownBrand":5,"enterTelphone":12,"enterWebsite":35,"business":36,"performance":40,"socialSecurity":41,"registrationNumber":42,"enterQq":5,"enterMail":37,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"status":16,"regtrademark":5,"remark":5},"43792","开业","652人","511000000014084",{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"id":5,"brandId":5,"brandName":5,"busmodel":5,"franchiseFund":5,"totalStores":5,"devmodel":5,"franchiseIndustry":5,"investmenttel":5,"suitablePeople":5,"state":5},[],[],[47],{"createTime":48,"updateTime":49,"createBy":5,"updateBy":5,"industryId":50,"webId":5,"industryName":51,"industryAlias":52,"industryIcon":5,"industryTrans":53,"pageTitle":54,"pageDesc":55,"pageKeywords":56,"mainTitle":57,"pageSubtitle":58,"indSummary":59,"industryLevel":60,"parentId":61,"parentName":62,"sortOrder":63,"status":16,"classifyVisit":64,"totalVisits":65,"searchName":5,"starLevel":5,"limit":5},"2000-01-01 00:00:00","2026-06-14 16:50:00","5593","药品","药品,药物,医药制剂,医疗药品,医用药品,药片","\u002Fprofile\u002Fupload\u002F2023\u002F11\u002F08\u002F175454c1767ce2414a13f8c3c16194de.png","十大药品品牌-药品十大厂家-ZGALL品牌榜","2026年药品行业十大品牌权威发布！药品排行榜前十名品牌有三九、同仁堂、广药白云山、云南白药、太极药业、修正、念慈菴、天士力、扬子江药业、仁和。药品10大品牌由品牌中国重磅推出，旨在呈现行业领域标杆品牌，展现行业优秀企业实力，帮助你了解药品哪个牌子好。","药品十大品牌排名,OTC药品十大品牌,非处方药品牌十大排行榜,OTC药品排行,药品品牌有哪些","药品品牌排行榜","2026药品品牌排行榜，OTC药品排行，OTC常用药品有哪些","药品什么牌子好？品牌TOP榜权威发布2026年药品十大品牌名录；居前十的有：三九999、同仁堂、广药白云山、云南白药、太极药业TAIJI、修正、京都念慈菴、天士力TASLY、扬子江药业、仁和药业RenHe等，【行业品牌名录】基于大数据与人工智能技术，整合300+国际权威榜单及企业申报数据，通过算法分析市场占有率、创新力等12项指标，并解析超百万条舆情信息，采用加权模型（算法60%+专家30%+用户10%）生成动态排名。数据月度更新，申报需通过ISO认证审核，排名不分先后，仅供参考。",3,1411,"医药用品",20,9,1054]